IN187739B - - Google Patents

Info

Publication number
IN187739B
IN187739B IN358CA1997A IN187739B IN 187739 B IN187739 B IN 187739B IN 358CA1997 A IN358CA1997 A IN 358CA1997A IN 187739 B IN187739 B IN 187739B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Maryvonne Chariot
Gareth Lewis
Jean Montel
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IN187739B publication Critical patent/IN187739B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IN358CA1997 1996-03-04 1997-02-27 IN187739B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (1)

Publication Number Publication Date
IN187739B true IN187739B (de) 2002-06-15

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
IN358CA1997 IN187739B (de) 1996-03-04 1997-02-27

Country Status (35)

Country Link
US (2) US6165507A (de)
EP (1) EP0906101B1 (de)
JP (2) JP2000512617A (de)
KR (1) KR100369888B1 (de)
CN (1) CN1112929C (de)
AR (1) AR006082A1 (de)
AT (1) ATE219365T1 (de)
AU (1) AU725494B2 (de)
BG (1) BG63451B1 (de)
BR (1) BR9707827A (de)
CA (1) CA2247405C (de)
CO (1) CO4780020A1 (de)
CY (1) CY2293B1 (de)
CZ (1) CZ291418B6 (de)
DE (1) DE69713505T2 (de)
DK (1) DK0906101T3 (de)
EE (1) EE03511B1 (de)
ES (1) ES2177942T3 (de)
FR (1) FR2745500B1 (de)
HK (1) HK1017999A1 (de)
HU (1) HU227472B1 (de)
IL (1) IL126050A (de)
IN (1) IN187739B (de)
NO (1) NO315841B1 (de)
NZ (1) NZ331947A (de)
OA (1) OA10854A (de)
PL (1) PL189813B1 (de)
PT (1) PT906101E (de)
RU (1) RU2173997C2 (de)
SK (1) SK282112B6 (de)
TR (1) TR199801574T2 (de)
TW (1) TW491711B (de)
UA (1) UA49004C2 (de)
WO (1) WO1997032584A1 (de)
ZA (1) ZA971830B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
EP1322158B1 (de) * 2000-10-02 2012-08-08 USV Ltd. Metformin enthaltende pharmazeutische Zusammensetzungen mit verzögerter Wirkstofffreigabe und Verfahren zu deren Herstellung
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CA2518442A1 (en) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
CA2936400C (en) * 2008-07-28 2018-03-27 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
SK282112B6 (sk) 2001-11-06
WO1997032584A1 (fr) 1997-09-12
SK121098A3 (en) 1999-01-11
CY2293B1 (en) 2003-07-04
OA10854A (fr) 2003-02-05
NZ331947A (en) 2000-03-27
JP2007182451A (ja) 2007-07-19
EE9800275A (et) 1999-02-15
JP2000512617A (ja) 2000-09-26
CZ279198A3 (cs) 1999-01-13
BG63451B1 (bg) 2002-02-28
IL126050A (en) 2004-05-12
EE03511B1 (et) 2001-10-15
DE69713505D1 (de) 2002-07-25
ATE219365T1 (de) 2002-07-15
AU1930097A (en) 1997-09-22
RU2173997C2 (ru) 2001-09-27
TW491711B (en) 2002-06-21
HUP9902458A2 (hu) 2000-05-28
CZ291418B6 (cs) 2003-03-12
US6165507A (en) 2000-12-26
CA2247405A1 (en) 1997-09-12
KR19990087387A (ko) 1999-12-27
CN1112929C (zh) 2003-07-02
CN1212624A (zh) 1999-03-31
KR100369888B1 (ko) 2003-05-17
HK1017999A1 (en) 1999-12-10
FR2745500A1 (fr) 1997-09-05
ES2177942T3 (es) 2002-12-16
NO984035D0 (no) 1998-09-02
HUP9902458A3 (en) 2002-11-28
UA49004C2 (uk) 2002-09-16
TR199801574T2 (xx) 1998-11-23
NO984035L (no) 1998-10-22
BG102692A (en) 1999-04-30
CA2247405C (en) 2004-04-20
IL126050A0 (en) 1999-05-09
ZA971830B (en) 1997-09-04
DE69713505T2 (de) 2003-02-13
US20050202089A1 (en) 2005-09-15
NO315841B1 (no) 2003-11-03
PL328763A1 (en) 1999-02-15
HU227472B1 (en) 2011-07-28
PT906101E (pt) 2002-09-30
AR006082A1 (es) 1999-08-11
BR9707827A (pt) 1999-07-27
AU725494B2 (en) 2000-10-12
FR2745500B1 (fr) 1998-04-03
EP0906101A1 (de) 1999-04-07
EP0906101B1 (de) 2002-06-19
PL189813B1 (pl) 2005-09-30
CO4780020A1 (es) 1999-05-26
DK0906101T3 (da) 2002-10-14

Similar Documents

Publication Publication Date Title
AR026659A2 (de)
ITMI960250A0 (de)
IN186139B (de)
ITMI960615A0 (de)
IN187739B (de)
ITMI960714A0 (de)
ITMI960558V0 (de)
ITMI960532V0 (de)
ITMI960307A0 (de)
ITBS960072V0 (de)
ECSDI960367S (de)
ECSDI960348S (de)
CN3047348S (de)
CN3046379S (de)
CN3047788S (de)
CN3047747S (de)
CN3047746S (de)
CN3047648S (de)
CN3047647S (de)
CN3047597S (de)
CN3047496S (de)
CN3047495S (de)
CN3047494S (de)
CN3047493S (de)
CN3047252S (de)